JACOBUS 25 102 (Dapsone 25 mg)
Pill with imprint JACOBUS 25 102 is White, Round and has been identified as Dapsone 25 mg. It is supplied by Jacobus Pharmaceutical Company.
Dapsone is used in the treatment of dermatitis herpetiformis; leprosy; leprosy, lepromatous; leprosy, tuberculoid; pneumocystis pneumonia and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for JACOBUS 25 102
Dapsone
- Imprint
- JACOBUS 25 102
- Strength
- 25 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Leprostatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jacobus Pharmaceutical Company
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 49938-0102 | Jacobus Pharmaceutical Company Inc. |
| 13925-0504 | Seton Pharmaceuticals LLC |
| 55289-0188 (Discontinued) | PDRX Pharmaceuticals Inc. (repackager) |
| 54868-2817 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about dapsone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (21)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: leprostatics
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.